US Patent Issued to Diamond Therapeutics on March 31 for "Amorphous (a-polymorphic) psilocybin" (Canadian, German Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,110, issued on March 31, was assigned to Diamond Therapeutics Inc. (Toronto).

"Amorphous (a-polymorphic) psilocybin" was invented by Judith Blumstock (Toronto), David Roger Brown (Pickering, Canada), Christian Steup (Kelkheim, Germany) and Marc Zeplichal (Reinheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising amorphous psilocybin. The amorphous psilocybin may be a synthetic, a-polymorphic psilocybin. Also disclosed herein are methods of treatment using amorphous psilocybin and methods of manufacturing amorphous psilocybin."

The patent was filed on July 5, 2024, under Application No. 18/764,635...